MD Anderson Cancer Center Department of Lymphoma & Myeloma

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Lymphoma, B-Cell

Studies at this site

• A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) — Stopped early
• A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) — Completed